138 related articles for article (PubMed ID: 32349159)
1. Steroidogenesis in the NCI-H295 Cell Line Model is Strongly Affected By Culture Conditions and Substrain.
Kurlbaum M; Sbiera S; Kendl S; Martin Fassnacht M; Kroiss M
Exp Clin Endocrinol Diabetes; 2020 Oct; 128(10):672-680. PubMed ID: 32349159
[TBL] [Abstract][Full Text] [Related]
2. Mitotane exhibits dual effects on steroidogenic enzymes gene transcription under basal and cAMP-stimulating microenvironments in NCI-H295 cells.
Lin CW; Chang YH; Pu HF
Toxicology; 2012 Aug; 298(1-3):14-23. PubMed ID: 22546480
[TBL] [Abstract][Full Text] [Related]
3. Mitotane Inhibits Sterol-O-Acyl Transferase 1 Triggering Lipid-Mediated Endoplasmic Reticulum Stress and Apoptosis in Adrenocortical Carcinoma Cells.
Sbiera S; Leich E; Liebisch G; Sbiera I; Schirbel A; Wiemer L; Matysik S; Eckhardt C; Gardill F; Gehl A; Kendl S; Weigand I; Bala M; Ronchi CL; Deutschbein T; Schmitz G; Rosenwald A; Allolio B; Fassnacht M; Kroiss M
Endocrinology; 2015 Nov; 156(11):3895-908. PubMed ID: 26305886
[TBL] [Abstract][Full Text] [Related]
4. Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis.
Gazdar AF; Oie HK; Shackleton CH; Chen TR; Triche TJ; Myers CE; Chrousos GP; Brennan MF; Stein CA; La Rocca RV
Cancer Res; 1990 Sep; 50(17):5488-96. PubMed ID: 2386954
[TBL] [Abstract][Full Text] [Related]
5. Aminoglutethimide suppresses adrenocorticotropin receptor expression in the NCI-h295 adrenocortical tumor cell line.
Fassnacht M; Beuschlein F; Vay S; Mora P; Allolio B; Reincke M
J Endocrinol; 1998 Oct; 159(1):35-42. PubMed ID: 9795339
[TBL] [Abstract][Full Text] [Related]
6. Drug Synergism of Proteasome Inhibitors and Mitotane by Complementary Activation of ER Stress in Adrenocortical Carcinoma Cells.
Kroiss M; Sbiera S; Kendl S; Kurlbaum M; Fassnacht M
Horm Cancer; 2016 Dec; 7(5-6):345-355. PubMed ID: 27631436
[TBL] [Abstract][Full Text] [Related]
7. Computational analysis of liquid chromatography-tandem mass spectrometric steroid profiling in NCI H295R cells following angiotensin II, forskolin and abiraterone treatment.
Mangelis A; Dieterich P; Peitzsch M; Richter S; Jühlen R; Hübner A; Willenberg HS; Deussen A; Lenders JW; Eisenhofer G
J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt A):67-75. PubMed ID: 26435452
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of digoxin and ouabain on aldosterone synthesis in human adrenocortical NCI-H295 cells.
Kau MM; Kan SF; Wang JR; Wang PS
J Cell Physiol; 2005 Dec; 205(3):393-401. PubMed ID: 15887230
[TBL] [Abstract][Full Text] [Related]
9. Modulation of glucocorticoid, mineralocorticoid and androgen production in H295 cells by Trimesemine™, a mesembrine-rich Sceletium extract.
Swart AC; Smith C
J Ethnopharmacol; 2016 Jan; 177():35-45. PubMed ID: 26608706
[TBL] [Abstract][Full Text] [Related]
10. CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells.
Germano A; Saba L; De Francia S; Rapa I; Perotti P; Berruti A; Volante M; Terzolo M
PLoS One; 2018; 13(5):e0196931. PubMed ID: 29734384
[TBL] [Abstract][Full Text] [Related]
11. Physiological and drug-induced changes in blood levels of adrenal steroids and their precursors in cynomolgus monkeys: An application of steroid profiling by LC-MS/MS for evaluation of the adrenal toxicity.
Tochitani T; Yamashita A; Matsumoto I; Kouchi M; Fujii Y; Yamada T; Miyawaki I
J Toxicol Sci; 2019; 44(9):575-584. PubMed ID: 31474739
[TBL] [Abstract][Full Text] [Related]
12. Regulation of steroidogenesis in NCI-H295 cells: a cellular model of the human fetal adrenal.
Staels B; Hum DW; Miller WL
Mol Endocrinol; 1993 Mar; 7(3):423-33. PubMed ID: 8387159
[TBL] [Abstract][Full Text] [Related]
13. The NCI-H295 cell line: a pluripotent model for human adrenocortical studies.
Rainey WE; Bird IM; Mason JI
Mol Cell Endocrinol; 1994 Apr; 100(1-2):45-50. PubMed ID: 8056157
[TBL] [Abstract][Full Text] [Related]
14. Association of mitotane with chylomicrons and serum lipoproteins: practical implications for treatment of adrenocortical carcinoma.
Kroiss M; Plonné D; Kendl S; Schirmer D; Ronchi CL; Schirbel A; Zink M; Lapa C; Klinker H; Fassnacht M; Heinz W; Sbiera S
Eur J Endocrinol; 2016 Mar; 174(3):343-53. PubMed ID: 26671975
[TBL] [Abstract][Full Text] [Related]
15. Comparison of expression and regulation of the high-density lipoprotein receptor SR-BI and the low-density lipoprotein receptor in human adrenocortical carcinoma NCI-H295 cells.
Martin G; Pilon A; Albert C; Vallé M; Hum DW; Fruchart JC; Najib J; Clavey V; Staels B
Eur J Biochem; 1999 Apr; 261(2):481-91. PubMed ID: 10215860
[TBL] [Abstract][Full Text] [Related]
16. Local renin-angiotensin system is involved in K+-induced aldosterone secretion from human adrenocortical NCI-H295 cells.
Hilbers U; Peters J; Bornstein SR; Correa FM; Jöhren O; Saavedra JM; Ehrhart-Bornstein M
Hypertension; 1999 Apr; 33(4):1025-30. PubMed ID: 10205242
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of bufalin and cinobufagin on steroidogenesis via the activation of ERK in human adrenocortical cells.
Kau MM; Wang JR; Tsai SC; Yu CH; Wang PS
Br J Pharmacol; 2012 Mar; 165(6):1868-1876. PubMed ID: 21913902
[TBL] [Abstract][Full Text] [Related]
18. The effect of mitotane on viability, steroidogenesis and gene expression in NCI‑H295R adrenocortical cells.
Lehmann TP; Wrzesiński T; Jagodziński PP
Mol Med Rep; 2013 Mar; 7(3):893-900. PubMed ID: 23254310
[TBL] [Abstract][Full Text] [Related]
19. Alterations of adrenal steroidomic profiles in preterm infants at birth.
Travers S; Martinerie L; Boileau P; Lombès M; Pussard E
Arch Dis Child Fetal Neonatal Ed; 2018 Mar; 103(2):F143-F151. PubMed ID: 28747362
[TBL] [Abstract][Full Text] [Related]
20. Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells.
Gagliano T; Gentilin E; Benfini K; Di Pasquale C; Tassinari M; Falletta S; Feo C; Tagliati F; Uberti ED; Zatelli MC
Endocrine; 2014 Dec; 47(3):943-51. PubMed ID: 25096913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]